Ibrutinib (PCI-32765)( Purity > 99% by HPLC)

Product Name: Ibrutinib (PCI-32765)
 CAT#: A-2112

Request Ibrutinib (PCI-32765)
 Synonym: PCI-32765; Ibrutinib, PCI32765; PCI 32765. ,

Ibrutinib (PCI-32765) Chemical Structure
Ibrutinib (PCI-32765)chemical structure

5 stars, based on 1836 reviews

IUPAC/Chemical name:

Price of Ibrutinib (PCI-32765)

We offer a substantial discount on larger orders,
please inquire via sales@activebiochem.com
or Fax: 1-201-884-1288 (USA Fax#)


Biological Activity
Ibrutinib, also known as PCI-32765, is a BTK inhibitor, is also an orally bioavailable small-molecule inhibitor of Bruton's tyrosine kinase (BTK) with potential antineoplastic activity. BTK inhibitor PCI-32765 binds to and inhibits BTK activity, preventing B-cell activation and B-cell-mediated signaling and inhibiting the growth of malignant B cells that overexpress BTK. BTK, a member of the src-related BTK/Tec family of cytoplasmic tyrosine kinases, is required for B cell receptor (BCR) signaling, plays a key role in B-cell maturation, and is overexpressed in a number of B-cell malignancies. Ibrutinib was approved by the US FDA on November 13, 2013 for the treatment of mantle cell lymphoma.
Technical Data

Purity: >99%
CAS#:936563-96-1
Chemical Formula:C25H24N6O2
Molecular Weight:440.49706
Ibrutinib (PCI-32765) MSDSIbrutinib (PCI-32765) CoA

IUPAC/Chemical name:(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
Canonical SMILES: C=CC(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC=C4)C=C3)C5=C(N)N=CN=C52)CCC1)=O
Reference





Purchase(buy) Ibrutinib (PCI-32765) at Active Biochem and the United State(U.S.), Germany, Japan, France,United Kingdom(UK),Switzerland, Australia distributors.